Singapore: China's leading pharmaceutical firm Yabao Pharmaceutical has inked a pact with the University of South Austra...
Singapore: Celgene International has received European Commission (EC) approval for VIDAZA (azacitidine for injection) f...
InvitroCue, the Australian company that works on advanced bio-analytics, has announced a key initiative on Malaria to id...
Singapore: Bionomics, Australia based biopharmaceutical company focused on the discovery and development of innovative t...
Singapore: The oncology drug pipeline is far larger than any other therapy area across the pharmaceutical industry, with...
Researchers affiliated with Kawasaki Innovation Gateway at SKYFRONT, Japan have discovered that incorporating gold nanop...
Singapore: Japan's Astellas Pharma and Potenza Therapeutics, a biotechnology company developing a portfolio of immuno-on...
Singapore: Singapore based ASLAN Pharmaceuticals, a biotech company focused on the development of immunotherapies and ta...
Tokyo: Japanese pharmaceutical giant, Daiichi Sankyo Company Limited has announced that its wholly-owned subsidiary in ...
Roche has announced that the company has entered into an agreement to develop a companion diagnostic (CDx) test for dalc...
Singapore: AstraZeneca has bought bulk biologics manufacturing capacity from Amgen in US to expand its biologics manufac...
Singapore: United States Patent Office has issued official "Letters Patent" on a key patent in the PAT-LM1 family; US pa...
Singapore: Orexo entered into an agreement with AstraZeneca regarding preclinical program OX-CLI for a potential novel t...
New York-based Progenics Pharmaceuticals' partner Fujifilm RI Pharma Co. Ltd. (Fuji) has dosed the first patient in its ...
Singapore: European firms, Crystal Bioscience and Boehringer Ingelheim, have entered into an agreement to collaborate on...
Japan' Daiichi Sankyo's domestic subsidiary, Daiichi Sankyo Espha Co Ltd. has obtained approval for partial changes conc...
Singapore: ASLAN Pharmaceuticals, Singapore based biotech company focused on the development of immunotherapies and targ...
Hyderabad: GVK Biosciences, Asia's leading drug discovery R&D organization, has received approvals from the Atomic ...
